PERK inhibitors: Difference between revisions
CSV import |
CSV import |
||
| Line 30: | Line 30: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 21:42, 17 March 2025
PERK inhibitors are a class of drugs that inhibit the protein kinase PERK. PERK, or Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase, is a type of enzyme that in humans is encoded by the EIF2AK3 gene. It is involved in the Unfolded Protein Response (UPR), a cellular stress response related to the endoplasmic reticulum.
Mechanism of Action[edit]
PERK inhibitors work by blocking the activity of the PERK enzyme. This enzyme is activated in response to the accumulation of unfolded proteins in the endoplasmic reticulum, a condition known as Endoplasmic Reticulum Stress (ERS). When activated, PERK phosphorylates the eukaryotic initiation factor 2 alpha (eIF2α), leading to a reduction in general protein synthesis but an increase in the translation of specific mRNAs such as ATF4.
By inhibiting PERK, these drugs can potentially modulate the UPR and have therapeutic effects in diseases where ERS and UPR are implicated, such as neurodegenerative diseases, cancer, and diabetes.
Clinical Use[edit]
Currently, PERK inhibitors are primarily used in research settings. However, they have potential therapeutic applications in a variety of diseases. For example, in neurodegenerative diseases like Alzheimer's disease and Parkinson's disease, PERK inhibition has been shown to reduce neuronal death and improve cognitive and motor function in animal models.
In cancer, PERK activation is often associated with tumor survival and growth, and its inhibition can potentially suppress tumor growth. In diabetes, PERK plays a role in beta-cell dysfunction and death, and its inhibition could potentially protect beta cells and improve insulin secretion.
Side Effects[edit]
As with any drug, PERK inhibitors can have side effects. These can include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include liver damage and kidney damage. However, these side effects are generally rare and the drugs are generally well tolerated in research settings.
See Also[edit]
